Evidence map›Paper›PMID 42510777›Full record

ArticleGenes2026

An

Qingzhu Liu, Ke Xu, Cong Zhou, Qikui Zhu, Junqin Lu, Yuqiao Tang, Chun Zhang, Wukun Xie, Guojiu Fang, Dasheng Tian and 5 more

Abstract read
In one paragraph

Article in Genes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Qingzhu LiuDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Ke XuDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Cong ZhouDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Qikui ZhuState Key Laboratory of Oral & Maxillofacial Reconstruction and Regeneration, School & Hospital of Stomatology, Wuhan University, Wuhan 430079, China.
Junqin LuDepartment of Orthopedics, The First People's Hospital of Lianyungang City, Lianyungang 222061, China.
Yuqiao TangCollege of Life Sciences, Wuhan University, Wuhan 430072, China.
Chun ZhangDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Wukun XieDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Guojiu FangDepartment of General Surgery, Shanghai Fengxian Central Hospital, Shanghai 201400, China.
Dasheng TianDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Juehua JingDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.ORCID 0000-0002-8224-0184
Yize LiDepartment of Medicine, Washington University in St. Louis, St. Louis, MO 63130, USA.ORCID 0000-0003-1074-281X
Wenxiu DuanDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.
Hongsheng WangDepartment of Traditional Chinese Medicine, Songjiang Research Institute, Shanghai Key Laboratory of Emotions and Affective Disorders, Songjiang Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 201600, China.
Yihui BiDepartment of Orthopaedics, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.ORCID 0009-0000-5486-9009

Funding

Anhui Medical University Foundation 9101224201National Natural Science Foundation Incubation Program of The Second Affiliated Hospital of Anhui Medical University 2021GQFY02National Natural Science Foundation of China 82201533
6 · The paper itself

Abstract

backgroundMetastasis and poor chemotherapy response have stagnated therapeutic progress in osteosarcoma (OS) for the past three decades. Defining the transition from localized to metastatic OS before overt dissemination is fundamental for improving survival. However, effective early diagnostic tools remain scarce, largely due to limited exploitation of the metastasis-associated tumor microenvironment's own record of prior environmental and stress exposures encoded in cell-intrinsic transcriptional states. Here, we employed a supervised machine learning framework with iterative resampling and multi-stage model selection to identify molecular markers associated with metastasis in osteosarcoma and to develop a computational signature,

methodsTranscriptomic and clinical data from 139 OS patients with ≥5 years of follow-up were analyzed. A LASSO-Cox framework was applied to derive a gene expression-based risk score,

results

conclusionsWe identified autophagy-mediated transcriptional 'stress fingerprints' that are tightly associated with OS metastasis. The

Indexed as

Biomarkers, TumorBone NeoplasmsDrug Resistance, NeoplasmOsteosarcomaTranscriptomeAdolescentAdultFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMalePrognosisTumor MicroenvironmentBiomarkers, Tumordrug sensitivity predictionmachine learningosteosarcomaprognostic biomarkerrisk stratificationsingle-cell analysis

Identifiers

PMID42510777
PMCPMC13408425

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.